• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病中标志性自身抗体反应对早期诊断的影响。

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

机构信息

Centre for Rheumatology, Royal Free Hospital and UCL Medical School, London, UK.

出版信息

Clin Rev Allergy Immunol. 2012 Dec;43(3):249-55. doi: 10.1007/s12016-012-8331-1.

DOI:10.1007/s12016-012-8331-1
PMID:22711501
Abstract

Raynaud's phenomenon often precedes the diagnosis of systemic sclerosis and is the first symptom of the disease in many cases. Antinuclear antibody positivity can assist in the early identification of cases of isolated Raynaud's phenomenon likely to progress to systemic sclerosis. However, the specific differences between rate of progression for different scleroderma hallmark antibodies is less clear. We review the predictive potential of ANA positivity and nailfold capillaroscopy for identifying cases of Raynaud's phenomenon which may progress to connective tissue diseases. We also have reviewed data from our own large scleroderma cohort to explore the relationship between antibody subtype and time to development of SSc. Duration of pre-existing Raynaud's phenomenon may be an important determinant of the profile of systemic sclerosis cases identified through screening. Ninety-five percent of our patients with isolated Raynaud's phenomenon, negative autoimmune serology on more than one visit and normal capillaroscopy score showed no progression to connective tissue disease. Duration of antecedent Raynaud's phenomenon differs between disease subsets and scleroderma-specific ANA patterns.

摘要

雷诺现象常先于系统性硬化症的诊断,且在许多情况下是该病的首发症状。抗核抗体阳性有助于早期识别可能进展为系统性硬化症的孤立性雷诺现象病例。然而,不同硬皮病标志性抗体的进展速度之间的具体差异尚不清楚。我们回顾了 ANA 阳性和甲襞毛细血管镜检查对识别可能进展为结缔组织疾病的雷诺现象病例的预测潜力。我们还回顾了来自我们自己的大型硬皮病队列的数据,以探讨抗体亚型与发生 SSc 的时间之间的关系。预先存在的雷诺现象的持续时间可能是通过筛查确定的系统性硬化症病例特征的一个重要决定因素。在我们的孤立性雷诺现象患者中,95%的患者在多次就诊时自身免疫血清学检查均为阴性,且毛细血管镜评分正常,没有进展为结缔组织疾病。疾病亚组和特异性抗核抗体模式之间的先前存在的雷诺现象的持续时间不同。

相似文献

1
Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.硬皮病中标志性自身抗体反应对早期诊断的影响。
Clin Rev Allergy Immunol. 2012 Dec;43(3):249-55. doi: 10.1007/s12016-012-8331-1.
2
Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud's phenomenon.无雷诺现象患者的甲襞毛细血管镜检查用于硬皮病谱系疾病的早期诊断。
J Scleroderma Relat Disord. 2022 Jun;7(2):144-150. doi: 10.1177/23971983221088460. Epub 2022 Apr 21.
3
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).雷诺现象患者进展为系统性硬化症:欧洲硬皮病试验与研究组多中心、系统性硬化症极早期诊断纵向注册研究(VEDOSS)的五年分析。
Lancet Rheumatol. 2021 Dec;3(12):e834-e843. doi: 10.1016/S2665-9913(21)00244-7.
4
Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders.甲襞出血在硬皮病谱系障碍中的诊断意义
J Am Acad Dermatol. 1993 Feb;28(2 Pt 1):198-203. doi: 10.1016/0190-9622(93)70027-q.
5
Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.儿童雷诺现象。临床、免疫学及毛细血管镜检查研究。
J Mal Vasc. 1992;17(4):273-6.
6
Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.早期系统性硬化症(VEDOSS)EUSTAR 多中心研究的初步分析:肿胀手指作为怀疑系统性硬化症的关键征象的证据。
Ann Rheum Dis. 2014 Dec;73(12):2087-93. doi: 10.1136/annrheumdis-2013-203716. Epub 2013 Aug 12.
7
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.雷诺现象患者的抗核抗体:抗着丝点抗体的临床意义。
Ann Rheum Dis. 1982 Aug;41(4):382-7. doi: 10.1136/ard.41.4.382.
8
Nailfold capillaroscopy in the screening and diagnosis of Raynaud's phenomenon.甲襞毛细血管镜检查在雷诺现象筛查与诊断中的应用
Angiology. 1994 Jan;45(1):37-42. doi: 10.1177/000331979404500105.
9
From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach.从雷诺现象到系统性硬化症的极早期诊断——VEDOSS方法
Curr Rheumatol Rev. 2013;9(4):245-8. doi: 10.2174/157339710904140417124819.
10
[Raynaud's phenomenon - first sign of malignancy: case report].[雷诺现象——恶性肿瘤的首发症状:病例报告]
Acta Med Croatica. 2014 Jun;68(3):295-8.

引用本文的文献

1
Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset.重新定义系统性硬化症的分类:与局限性皮肤型系统性硬化症亚组相比,抗拓扑异构酶抗体是间质性肺病和皮肤进展的更优预测指标。
Life (Basel). 2025 Jul 4;15(7):1067. doi: 10.3390/life15071067.
2
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.从疑似到明确的系统性硬化症的进展和抗拓扑异构酶 I 抗体的作用。
RMD Open. 2023 Feb;9(1). doi: 10.1136/rmdopen-2022-002827.
3
Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

本文引用的文献

1
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.南澳大利亚硬皮病登记处:自身抗体作为表型和预后的预测生物标志物。
Int J Rheum Dis. 2012 Feb;15(1):102-9. doi: 10.1111/j.1756-185X.2011.01688.x. Epub 2011 Nov 30.
2
Diagnosis and management of Raynaud's phenomenon.雷诺现象的诊断与管理
BMJ. 2012 Feb 7;344:e289. doi: 10.1136/bmj.e289.
3
Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers.通过毛细血管显微镜对健康志愿者甲襞毛细血管进行定性和定量评估。
系统性硬化症中的经典疾病特异性自身抗体:临床特征、基因易感性及疾病分层
Front Med (Lausanne). 2020 Nov 19;7:587773. doi: 10.3389/fmed.2020.587773. eCollection 2020.
4
Antinuclear Antibodies in Systemic Sclerosis: an Update.抗核抗体在系统性硬化症中的研究进展。
Clin Rev Allergy Immunol. 2020 Feb;58(1):40-51. doi: 10.1007/s12016-018-8718-8.
5
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.来自伴有雷诺现象的系统性硬化相关疾病的含抗 CENP-B 和抗 TOPO-1 的血清通过非经典 p53-p21 途径诱导血管内皮细胞衰老。
Clin Rheumatol. 2018 Mar;37(3):749-756. doi: 10.1007/s10067-017-3845-9. Epub 2017 Sep 23.
6
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis.系统性硬化症患者标准化综合护理路径的治疗和诊断结果。
RMD Open. 2016 Mar 15;2(1):e000159. doi: 10.1136/rmdopen-2015-000159. eCollection 2016.
7
Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.内皮功能障碍和甲襞微血管镜检查模式作为系统性硬化症中手指溃疡的预测指标:一项队列研究及文献综述
Clin Rev Allergy Immunol. 2015 Oct;49(2):240-52. doi: 10.1007/s12016-015-8500-0.
8
How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.地区综合医院的免疫学服务应如何筛查抗核抗体?一项“实地”审计。
Clin Exp Immunol. 2015 Apr;180(1):52-7. doi: 10.1111/cei.12556.
9
The challenge of treating orphan disease.治疗罕见病的挑战。
Clin Rev Allergy Immunol. 2014 Dec;47(3):259-63. doi: 10.1007/s12016-014-8462-7.
10
Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review.干细胞治疗自身免疫性风湿病:全面综述。
Clin Rev Allergy Immunol. 2014 Oct;47(2):244-57. doi: 10.1007/s12016-014-8445-8.
Vasa. 2012 Jan;41(1):19-26. doi: 10.1024/0301-1526/a000159.
4
Validation of potential classification criteria for systemic sclerosis.系统性硬化症潜在分类标准的验证。
Arthritis Care Res (Hoboken). 2012 Mar;64(3):358-67. doi: 10.1002/acr.20684.
5
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.制定系统性硬化症修订分类标准的项目:共识性工作的结果。
Arthritis Care Res (Hoboken). 2012 Mar;64(3):351-7. doi: 10.1002/acr.20679.
6
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.德国系统性硬皮病网络患者中与疾病相关的核自身抗体和其他核自身抗体的频率:与特征性临床特征的相关性。
Arthritis Res Ther. 2011;13(5):R172. doi: 10.1186/ar3495. Epub 2011 Oct 21.
7
Contemporary management of Raynaud's phenomenon and digital ischaemic complications.雷诺现象和数字缺血性并发症的当代治疗。
Curr Opin Rheumatol. 2011 Nov;23(6):555-61. doi: 10.1097/BOR.0b013e32834aa40b.
8
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.早期系统性硬化症的初步诊断标准:EULAR 硬皮病试验和研究组德尔菲共识研究的结果。
Ann Rheum Dis. 2011 Mar;70(3):476-81. doi: 10.1136/ard.2010.136929. Epub 2010 Nov 15.
9
Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.同一枚硬币的两面:硬皮病中的雷诺现象和指(趾)溃疡。
Autoimmun Rev. 2011 Mar;10(5):241-3. doi: 10.1016/j.autrev.2010.09.008. Epub 2010 Sep 21.
10
Autoantibodies as predictive tools in systemic sclerosis.自身抗体作为系统性硬化症的预测工具。
Nat Rev Rheumatol. 2010 Feb;6(2):112-6. doi: 10.1038/nrrheum.2009.238.